Description

6,7-Dibromo-1,4-Dihydroquinoxaline-2,3-Dione is a halogenated quinoxalinedione derivative, a specialized heterocyclic building block of significant interest in advanced organic synthesis. Its core value lies in its unique molecular scaffold, which serves as a versatile precursor for the development of novel compounds with potential biological activity. This high-purity intermediate is primarily needed by research institutions and pharmaceutical companies engaged in medicinal chemistry, particularly for the synthesis of complex molecules targeting neurological and oncological pathways.

Application

• Pharmaceutical Intermediate: Key synthetic precursor in the research and development of new active pharmaceutical ingredients (APIs), particularly for central nervous system (CNS) and oncology targets.
• Medicinal Chemistry Research: Used as a core scaffold for structure-activity relationship (SAR) studies and library synthesis to discover novel bioactive compounds.
• Organic Synthesis Building Block: Employed in the construction of complex heterocyclic systems, including fused ring structures, due to its reactive dibromo and dione functionalities.
• Agrochemical Research: Potential intermediate in the development of new herbicides or fungicides, leveraging its halogenated quinoxaline structure.
• Material Science Precursor: Investigated for the synthesis of organic electronic materials, such as ligands for metal-organic frameworks (MOFs) or components for organic semiconductors.
• Biochemical Probe Development: Serves as a starting point for creating fluorescent dyes or molecular probes for biological imaging and diagnostic applications.

Basic Information

Product Name	6,7-Dibromo-1,4-Dihydroquinoxaline-2,3-Dione
CAS No.	89891-77-0
Molecular Formula	C8H4Br2N2O2
Molecular Weight	335.94 g/mol
Synonyms	6,7-Dibromoquinoxaline-2,3(1H,4H)-dione; 6,7-Dibromo-2,3-dihydroxyquinoxaline; 6,7-Dibromo-1,4-dihydro-2,3-quinoxalinedione; 2,3-Dihydroxy-6,7-dibromoquinoxaline; 6,7-Dibromo-2,3-dioxo-1,4-dihydroquinoxaline; DBQ; 6,7-Dibromoquinoxaline-2,3-diol
EINECS	Contact for details

Quality Control

Our 6,7-Dibromo-1,4-Dihydroquinoxaline-2,3-Dione is manufactured under strict quality management systems to ensure batch-to-batch consistency and high purity for research applications. Each lot undergoes comprehensive analytical characterization, including HPLC for purity and NMR for structural confirmation. Certificates of Analysis (COA) detailing all test results are provided with every shipment to support your R&D and regulatory documentation needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at room temperature (15-25°C). This compound is light-sensitive (store away from light) and may be hygroscopic (moisture-sensitive); therefore, containers should be kept sealed under an inert atmosphere when not in use to prevent degradation.

Specification

Item	Specification
Appearance	Yellow to light brown crystalline powder
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Melting Point	Contact for details
Loss on Drying	≤ 1.0%
Residue on Ignition	≤ 0.5%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.